Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00946881|
Recruitment Status : Completed
First Posted : July 27, 2009
Results First Posted : November 6, 2017
Last Update Posted : February 12, 2019
|Study Design||Intervention Model: Single Group Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Drug: WST 11 -mediated -VTP
Thirty patients were included in the study by five different centers in the US. All 30 patients received the entire VTP procedure (first treatment phase).
Two of them discontinued the study prior to Month 12. Eight patients who had positive biopsies at Month 6 entered in the retreatment phase. Only 7 of them actually received retreatment.